[6] in patients undergoing esophagogastroduodenoscopy under deep sedation or general anaesthesia revealed that RGC was present in 8 (24.2%) patients in the semaglutide group as compared to 19 (5.1%) among the non-users ( P 0.8 mL kg 1 measured from suction canister
GLP-1 Medications for Weight Loss: Mounjaro vs Ozempic vs Wegovy vs Rybelsus The rise of GLP-1 weight loss medications such as Mounjaro (Tirzepatide) , Ozempic , Wegovy , and Rybelsus has revolutionised medical weight management
Patients often report improved focus, enhanced mood, and greater stamina after treatment
Patients who learn how to adjust their eating habits may have better success staying on the medication
Originally developed to help manage Type 2 diabetes, these medications have shown significant promise in the weight loss space, helping patients feel fuller longer, reduce cravings, and control portion sizes